Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Adagio Medical Holdings, Inc. (ADGM : NSDQ)

• Company Description    Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif. Number of Employees: 71

• Price / Volume Information    Yesterday's Closing Price: $1.04 Daily Weekly Monthly 20 Day Moving Average: 281,424 shares Shares Outstanding: 15.38 (millions) Market Capitalization: $16.00 (millions) Beta: 0.13 52 Week High: $2.58 52 Week Low: $0.63 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.77% 16.97% 12 Week -55.69% -56.40% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 26051 MERIT CIRCLE SUITE 102 - LAGUNA HILLS,CA 92653 USA ph: 949-348-1188 fax: - ir@adagiomedical.com http://www.adagiomedical.com

• General Corporate Information    Officers Todd Usen - Chief Executive Officer John Dahldorf - Chief Financial Officer James L. Cox - Director Orly Mishan - Director Keyvan Mirsaeedi-Farahani - Director Peer Information Adagio Medical Holdings, Inc. (ABMD) Adagio Medical Holdings, Inc. (DMDS) Adagio Medical Holdings, Inc. (CPWY.) Adagio Medical Holdings, Inc. (EQUR) Adagio Medical Holdings, Inc. (ECIA) Adagio Medical Holdings, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 00534B100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 15.38 Most Recent Split Date: (:1) Beta: 0.13 Market Capitalization: $16.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 26.57 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -88.57% Sales Growth vs. Year Ago Period: -33.50% vs. Previous Quarter: -25.95% ROE 12/31/25 - - 09/30/25 - -791.01 06/30/25 - -248.26 ROA 12/31/25 - - 09/30/25 - -199.58 06/30/25 - -125.31 Current Ratio 12/31/25 - - 09/30/25 - 0.84 06/30/25 - 2.50 Quick Ratio 12/31/25 - - 09/30/25 - 0.68 06/30/25 - 2.13 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -57,254.02 06/30/25 - -22,654.97 Book Value 12/31/25 - - 09/30/25 - -0.09 06/30/25 - 0.56 Inventory Turnover 12/31/25 - - 09/30/25 - 1.04 06/30/25 - 0.99 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 1.96 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 66.16

Powered by Zacks Investment Research ©